Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Phlow Corp. See All Filings	D	2025-02-14 13:01:55 UTC
Amount To Be Raised $40,000,000 Associated Brokers / Dealers N/A CIK Number 0001832917 Filed Document 0001832917-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-02-14 13:01:55 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business VIRGINIA Revenue or Assets Decline to Disclose Type of Security Equity
Phlow Corp. See All Filings	D	2024-07-10 11:06:41 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001832917 Filed Document 0001832917-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-07-10 11:06:41 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business VIRGINIA Revenue or Assets Decline to Disclose Type of Security Debt
Phlow Corp. See All Filings	D	2022-09-02 15:53:32 UTC
Amount To Be Raised $50,000,000 Associated Brokers / Dealers N/A CIK Number 0001832917 Filed Document 0001832917-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-09-02 15:53:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business VIRGINIA Revenue or Assets Decline to Disclose Type of Security Equity
Phlow Corp. See All Filings	D	2020-11-19 18:14:16 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001832917 Filed Document 0001567619-20-020116 Exclusions or Exemptions 506b Accepted Date 2020-11-19 18:14:16 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business VIRGINIA Revenue or Assets Decline to Disclose Type of Security Equity
Phlow Corp. See All Filings	D	2020-11-18 17:25:12 UTC
Amount To Be Raised $8,062,500 Associated Brokers / Dealers N/A CIK Number 0001832917 Filed Document 0001567619-20-020055 Exclusions or Exemptions 506b Accepted Date 2020-11-18 17:25:12 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business VIRGINIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire